º¸¸£ÇǸ°(Áö¸ðÃßÃâ¹°)

Àû¸³±Ý 1 % Àû¸³

ÃßõÀÎ ÃßõÀξȳ» 3% Àû¸³

¹è¼Ûºñ (Á¶°Ç)

¿ë·®

      ÃÑ »óÇ° ±Ý¾× 0 ¿ø


      »ó¼¼Á¤º¸ »õâ ¿­±â

      »ó¼¼ Á¤º¸¸¦ È®´ëÇØ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.








      Á¦Ç°¸í º¸¸£ÇǸ°(Volufiline, Áö¸ðÃßÃâ¹°)
      INCI

      Hydrogenated Polyisobutene (and)
      Anemarrhena Asphodeloides Root Extract

      ¿ø»êÁö ÇÁ¶û½º(¼¼´õ¸¶) Á¦Ç°±â¿ø Áö¸ð(¹éÇÕ°ú ½Ä¹° ) »Ñ¸®

      ¼º»ó

      °¡º±°í ²öÀûÀÓÀÌ °ÅÀÇ ¾ø´Â Áö¿ë¼º ¾×»ó

      »ö»ó »öÀÌ °ÅÀÇ ¾ø°Å³ª ¿¬ÇÑ ³ë¶û

      Ãßõ»ç¿ëºÎÀ§

      °¡½¿, ¾ûµ¢ÀÌ, ¼Õµî, ¾ó±¼(À̸¶, º¼ µî)

      Ãßõ »ç¿ë·® 5% ³»¿Ü
      Á¦Ç°¼³¸í

      ¹× »ç¿ë·¹½ÃÇÇ

      º¸¸£ÇǸ°Àº Áö¹æÈ°¼ºÈ­ ¼ººÐÀ¸·Î ³ôÀº ¾ÈÀü¼º°ú ¼º´ÉÀ¸·Î
      Àü¼¼°èÀûÀ¸·Î ³Î¸® »ç¿ëµÇ´Â ¼ººÐÀÔ´Ï´Ù.
      º¸¸£ÇǸ°Àº È£¸£¸óÈ°¼º¿¡ ¿µÇâÀ» ÁÖÁö ¾Ê´Â ÇÇÅ佺Å×·ÑÀÔ´Ï´Ù.
      ¾Æ½Ã¾ÆÁö¿ª¿¡ ÀÚ»ýÇÏ´Â ½Ä¹°'Áö¸ð'ÀÇ »Ñ¸®¿¡¼­ ÃßÃâÇÑ ¼ººÐÀÔ´Ï´Ù.
      Promotes body volume by a cosmetic lipofilling-like effect.








      Demonstrated cosmetic activity (In vitro)

      1. The proliferation of adipocytes in the differentiation phase:
      o 20.5% increase with a concentration equivalent to 0.5% VOLUFILINE¢â
      o 35.2% increase with a concentration equivalent to 2% VOLUFILINE¢â

       

       2.The differentiation of pre-adipocytes as determined by G3PDH
      activity:
      o 103% increase with a concentration equivalent to 0.5% VOLUFILINE¢â
      o 535% increase with a concentration equivalent to 1.75% VOLUFILINE¢â

      3.Lipid uptake in cultured adipocytes 3T3-L1 and human
      adipocytes:
      o For cultured adipocytes 3T3-L1: 492% increase with a concentration
      equivalent to 1.75% VOLUFILINE¢â
      o For human adipocytes: 641% increase with a concentration equivalent to
      1% VOLUFILINE¢â


      4. Adipocyte volume:
      o 26-fold increase in cell volume with 1.5% VOLUFILINE¢â




      Demonstrated cosmetic activity (In vivo)

      28¸íÁö¿øÀÚ¿¡°Ô 56Àϵ¿¾È ÀÓ»ó ½ÃÇèÀ» Çß´Ù. 18¼¼~35¼¼ ¿©¼ºÀ» ¼±Á¤ÇØ 5%ÇÔÀ¯ °ÖŸÀÔÅ©¸²À» ÇÏ·ç¿¡ µÎ ¹ø ÇÑÂÊ °¡½¿¿¡¸¸ ¹Ù¸¥´Ù. ´ëÁ¶±ºÀ¸·Î ÇÑÂÊ¿¡´Â ¹Ù¸£Áö ¾Ê¾Ò½À´Ï´Ù.
      (½ÇÇè±â°£µ¿¾È ¸ö¹«°Ô´Â 3°³¿ù µ¿¾È À¯Áö, ÀÓ½ÅÇϰųª ¼öÀ¯¸¦ ÇÏÁö ¾ÊÀ½.
       È£¸£¸óÀÌ ±ÔÄ¢ÀûÀÌ°í ±¸°­ÇÇÀÓÀ» ÇÏÁö ¾ÊÀº »óÅÂ.) 


      °á°ú
        :  28
      ÀÏ ÈÄ  5% º¸¸£ÇǸ° ÇÔÀ¯Å©¸²À» ¹Ù¸¥ ÂÊÀº 1.4% º¼·ý Áõ°¡

      56ÀÏ ÈÄ 2.2% º¼·ý Áõ°¡

      Áö¿øÀÚ Áß »óÀ§ 25%´Â 28ÀÏ ÈÄ 6.4% º¼·ý Áõ°¡, 56ÀÏ ÈÄ¿¡´Â 8.4%Áõ°¡


       
       

      È°¿ë ·¹½ÃÇÇ ¾È³»:                                                                                                      
       º¸¸£ÇǸ° 100 ¾ÚÇÃ-º¸¸£ÇǸ° ¿ø¾×À» ±âÁ¸¿¡ »ç¿ëÇÏ´ø ¿ÀÀÏ, ·Î¼Ç, Å©¸² µî¿¡ Àû¿ëÇØ »ç¿ëÇÑ´Ù.    
        º¸¸£ÇǸ°5 ¼öºÐ¿¡¼¾½º-ÁغñÁß^^
                                                                                                                                                                                               
      º¸°ü¹æ¹ý

      15¡É~25¡É ±×´ÃÁö°í ¼­´ÃÇÑ °÷¿¡ º¸°üÇϼ¼¿ä.

      ÁÖÀÇ»çÇ×

      º¸¸£ÇǸ°Àº 80¡É¿¡¼­ 4½Ã°£ µ¿¾È °ßµô ¼ö ÀÖ½À´Ï´Ù.

      Ưº°È÷ Àû¿ëÀÌ ¾î·Á¿î pH´Â ¾ø½À´Ï´Ù.
      ¹Î°¨ , Áö¼ºÇǺÎÀÏ °æ¿ì ºÎºÐÀûÀ¸·Î Å×½ºÆ®Çغ¸¼¼¿ä.

      ¶Ç Áö¼ºÀ̳ª ¿©µå¸§ÀÇ °æ¿ì ¿ø¾×À» ¹Ù¸£½Ã¸é Áö¿ë¼º ¼ººÐÀ̱⠶§¹®¿¡

      »Ï·çÁö À¯¹ßÀ» ÇÒ ¼ö ÀÖÀ¸´Ï TÁ¸À» ÇÇÇØ »ç¿ëÇϽðí Èñ¼®ÇØ ÀûÀº ¾çÀ» »ç¿ëÇϼ¼¿ä.


      Çãºê´©¸® Ç°Áú°æ¿µ
      Çãºê´©¸® ÈıâÇýÅà »óÇ°Èı⾲±â ·¹½ÃÇÇÈı⾲±â ¼Ø¾¾ÀÚ¶û¾²±â
      Æ÷Åä»óÇ°Èıâ(68)
      ¾ÆÁ÷ ¸®ºä°¡ ¾ø¾î¿ä.
      ÀϹݻóÇ°Èıâ (361)
      2018³â ÀÌÀü »óÇ°Èıâ(91) 2010³âºÎÅÍ 2018³â 3¿ù±îÁö °í°´´ÔµéÀÌ ³²°ÜÁֽŠ¼ÒÁßÇÑ ÈıâÀÔ´Ï´Ù.
      »óÇ°¹®ÀÇ ( 108)
      µî·ÏµÈ ¹®ÀÇ°¡ ¾ø½À´Ï´Ù.

      ±³È¯/¹ÝÇ°/ȯºÒ/Ãë¼Ò

      ºñ¹Ð¹øÈ£ È®ÀÎ ´Ý±â